GSK-2647544 F-18

Investigational

Details

Stereochemistry	ACHIRAL
Molecular Formula	C24H18ClF3N4O3
Molecular Weight	501.875
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

FC(F)([18F])C1=CC(OC2=CC=C(CCOC3=NC(=O)C(CC4=CN=CN=C4)=CN3)C=C2)=CC=C1Cl

InChI

InChIKey=DRACNSAQZFZUKW-KPVNRNJOSA-N

InChI=1S/C24H18ClF3N4O3/c25-21-6-5-19(10-20(21)24(26,27)28)35-18-3-1-15(2-4-18)7-8-34-23-31-13-17(22(33)32-23)9-16-11-29-14-30-12-16/h1-6,10-14H,7-9H2,(H,31,32,33)/i26-1

HIDE SMILES / InChI

Molecular Formula	C24H18ClF3N4O3
Molecular Weight	501.875
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Mon Mar 31 18:46:58 GMT 2025` Edited by `admin` on `Mon Mar 31 18:46:58 GMT 2025`
Record UNII	Y12KJ6S66E
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

(18F)GSK-2647544

Preferred Name

English

GSK-2647544 F-18

Code

English

4(3H)-PYRIMIDINONE, 2-(2-(4-(4-CHLORO-3-((FLUORO-18)TRIFLUOROMETHYL)PHENOXY)PHENYL)ETHOXY)-5-(5-PYRIMIDINYLMETHYL)-

Systematic Name

English

[18F]GSK2647544

Code

English

Code System Code Type Description

PUBCHEM

135391014

Created by admin on Mon Mar 31 18:46:58 GMT 2025 , Edited by admin on Mon Mar 31 18:46:58 GMT 2025

PRIMARY

FDA UNII

Y12KJ6S66E

Created by admin on Mon Mar 31 18:46:58 GMT 2025 , Edited by admin on Mon Mar 31 18:46:58 GMT 2025

PRIMARY

CAS

2247636-10-6

Created by admin on Mon Mar 31 18:46:58 GMT 2025 , Edited by admin on Mon Mar 31 18:46:58 GMT 2025

PRIMARY

Related Record Type Details


					GKK5LY2UEI

GSK-2647544

NON-LABELED -> LABELED


					9LZ6G7HJ5R

PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE

TARGET->RADIOLIGAND

Amount:

Related Record Type Details


					Y12KJ6S66E

GSK-2647544 F-18

ACTIVE MOIETY

Amount: